text.skipToContent text.skipToNavigation
Need help? Please contact us
  1. Home
  2. renal

You searched for "renal"

Did you mean: read?
111 Products found
Too many choices? Use the filter option on the left to narrow your product listing.
  • 1(current)
  • 2
  • 3

You searched for "renal"

988 Documents found
  • 3D Natural Killer Cell-mediated Cytotoxicity Assay
    Lonza White Paper
  • Primary and Stem Cell Applications for Diabetes and Obesity Research
    Webinar - PDF Version
  • TechSheet - Human Dental Pulp Stem Cell Systems
    Technical Use and Product Information
  • Instructions - Human Dental Pulp Stem Cell Systems
    Instructions for Proper Use and Culture of Dental Pulp Stem Cells
  • Quality and Time: The Real Costs of Your Animal Neural Cell Isolation
    Lonza infographic illustrating the benefits of using Lonza's Ready-to-Use Cells
  • Lonza Celebrates the 30th Anniversary of Clonetics Products, the Pioneer of Primary Cells
    Lonza is pleased to announce that the Clonetics™ Primary Cells and Media product line is celebrating its 30th anniversary, supporting cell culture research.
  • Diabetes-related Differential Gene Expression in HAECs and ADSCs
    With the prevalence of diabetes growing worldwide, the availability of primary human cells from diabetic donors is critical to increase research and knowledge about the disease at a cellular level. In this study, we sought to identify genes differentially regulated in diabetic type 1 and type 2 adipose-derived stem cells (ADSCs) and human aortic endothelial cells (HAECs).
  • Primary Human Umbilical Vein Endothelial Cells
    Tech note demonstrating the successful development of tube formation assay using primary HUVECs that can be used to visualize angiogenesis in real-time.
  • FlashGel® Cassette News
    Simplified handling - New seals on your FlashGel® Cassette
  • The Cell and Gene Therapies Journey from Translation to Commercialization
    Download our comprehensive eBook on how to accelerate cell and gene therapy development, from translation to GMP production and commercialization.
  • Development of a Long-term Primary Hepatocyte 3D Spheroid Model
    For Use in DILI Applications using ViaLight Plus Cytotoxicity BioAssay Kit
  • Cold Storage of Fresh Leukopak Maintains Cell Viability and Functionality
    Learn how advanced cold storage approaches enable optimal levels of product integrity, quality, stability and viability
  • Cell culture and cell analysis using the Real Architecture for 3D Tissue (RAFT™) Culture System
    This poster explains how standard analysis techniques, like fluorescence microscopy, can be applied easily to RAFT™ 3D Cell Cultures. In addition, it will be shown how the RAFT™ Technology can be combined with transient transfection approaches using the Lonza 4D Nucleofector™ System.
  • Asthma- and COPD-related Differential Gene Expression in Primary Human Lung Fibroblasts
    A white paper exploring differential gene expression in primary human lung fibroblasts
  • Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force Awakens
    Poster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
  • Seamless Software Integration Allows for Enhanced Automation of the Entire Endotoxin Testing Workflow
    Enable new and more efficient processes by integrating an electronic batch record system along with endotoxin detection and analysis software.
  • Brochure - Cell List
    Integrated solutions for primary cells and transfection
  • DonorPlex™ Pooled Donor Human Hepatocytes Enable the Next Level of Reliability | Lonza
  • Cell List – Integrated Solutions for Primary Cells and Transfection
  • Designing an RNAi Experiment using Nucleofection® – Technical Reference Guide
    The success of an RNAi experiment can be influenced by several parameters. This guide describes the critical steps for setting up an RNAi experiment with siRNA oligos. Partially the guidelines also apply for shRNA.
  • 1
  • 2(current)
  • 3